Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences

The global pandemic of COVID-19 has attracted extensive drug searching interets for the new coronavirus SARS-CoV-2. Although currently several of clinically used “old” drugs have been repurposed to this new disease for the urgent clinical investigation, there is still great demand for more effective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Biomed
Main Authors: Wang, Aoli, Sun, Yong, Liu, Qingwang, Wu, Hong, Liu, Juan, He, Jun, Yu, Junling, Chen, Qing Qing, Ge, Yinglu, Zhang, Zhuhui, Hu, Chen, Chen, Cheng, Qi, Ziping, Zou, Fengming, Liu, Feiyang, Hu, Jie, Zhao, Ming, Huang, Tao, Wang, Beilei, Wang, Li, Wang, Wei, Wang, Wenchao, Ren, Tao, Liu, Jing, Sun, Yehuan, Fan, Song, Wu, Qibing, Liang, Chaozhao, Sun, Liangdan, Su, Bin, Wei, Wei, Liu, Qingsong
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700809/
https://ncbi.nlm.nih.gov/pubmed/34765997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43556-020-00018-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados